By exploring the patterns of engagement in several intellectual property (IP) marketplaces on the part of a sample of pharmaceutical firms based in Germany, the article attempts to shed light on the strategic reasons which induce firms to participate in different IP marketplaces and governance structures, often at the same time.  read more »